Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Exercise/Conversion of 2,477 KNSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,477 | n/a |
| Apr 13, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Sale | 1,703 | $79.5K |
| Apr 8, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Sale | 2,367 | $115.0K |
| Apr 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/Award | 879 | $21.2K |
| Sep 8, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Sale | 3,523 | $124.4K |
| Sep 3, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 1,741 | n/a |
| Jun 5, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 27,594 | $368.4K |
| May 5, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 3,850 | $68.4K |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 15,000 | $232.8K |
| Apr 23, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Sale | 18,259 | $370.5K |